Literature DB >> 26088451

Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway.

Yukina Nishio1, Takahiro Gojoubori2, Yasuhide Kaneko2, Noriyoshi Shimizu3, Masatake Asano4.   

Abstract

Aberrant activity of transcription factors in oral squamous cell carcinoma (OSCC) results in the spontaneous secretion of various cytokines and chemokines. Among them, IL-8, owing to its angiogenic activity, promotes the growth of OSCCs. In the present study, we examined the role of IL-8 secreted by OSCCs, on the angiogenic activity of monocytic THP1 cells. Culture supernatant (Ca-sup) augmented IL-8 secretion by THP1 cells, which was found to be significantly reduced following the removal Ca9-22-derived IL-8 from the Ca-sup. IL-8 induction was regulated at the transcriptional level, because real-time PCR demonstrated the augmented IL-8 messenger RNA (mRNA) expression. We further performed the luciferase assay using the 5'-untranslated region of IL-8 gene. Contradictory to our speculations, luciferase activity was not augmented by Ca-sup stimulation. NF-κB-independent IL-8 induction was further confirmed by pre-treating THP1 cells with NF-κB-specific inhibitors. To elucidate the signaling pathway, THP1 was pre-treated with MEK inhibitors. The results demonstrated that pre-treatment of cells with MEK inhibitor drastically reduced IL-8 levels, suggesting the role of MEK. Moreover, Ca-sup was found to increase ERK1/2 phosphorylation in a time-dependent manner. These results indicated that OSCC-derived IL-8 appears to activate angiogenic activity in monocytes within the tumor microenvironment via the mitogen-activated protein kinase (MAPK) pathway.

Entities:  

Keywords:  Interleukin-8; Macrophage; Mitogen-activated protein kinase; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26088451     DOI: 10.1007/s13277-015-3641-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers.

Authors:  J Fujimoto; H Sakaguchi; I Aoki; T Tamaya
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

Review 2.  The chemokine system and cancer.

Authors:  Frances R Balkwill
Journal:  J Pathol       Date:  2011-11-23       Impact factor: 7.996

3.  Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.

Authors:  Alok Mishra; Alok C Bharti; Prishla Varghese; Daman Saluja; Bhudev C Das
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

4.  Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.

Authors:  Cristiane H Squarize; Rogerio M Castilho; Virote Sriuranpong; Decio S Pinto; Jorge Silvio Gutkind
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

Review 5.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

Review 6.  Distinct role of macrophages in different tumor microenvironments.

Authors:  Claire E Lewis; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco.

Authors:  Meenakshi Sawhney; Nidhi Rohatgi; Jatinder Kaur; Shishir Shishodia; Gautam Sethi; Siddhartha D Gupta; Suryanaryana V S Deo; Nootan K Shukla; Bharat B Aggarwal; Ranju Ralhan
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

8.  Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.

Authors:  Y Kitadai; K Haruma; K Sumii; S Yamamoto; T Ue; H Yokozaki; W Yasui; Y Ohmoto; G Kajiyama; I J Fidler; E Tahara
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 9.  The interleukin-8 pathway in cancer.

Authors:  David J J Waugh; Catherine Wilson
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.

Authors:  Laura M Campbell; Pamela J Maxwell; David J J Waugh
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-06
View more
  6 in total

1.  Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

Authors:  Haiyan Yang; Zhenguo Liu; Cuncun Yuan; Yunfei Zhao; Lei Wang; Jiong Hu; Dacheng Xie; Liwei Wang; Donghui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation.

Authors:  Hualin Fu; Yue Ma; Meng Yang; Chunlei Zhang; Hai Huang; Ying Xia; Lungen Lu; Weilin Jin; Daxiang Cui
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

3.  IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.

Authors:  Leong-Perng Chan; Ling-Feng Wang; Feng-Yu Chiang; Ka-Wo Lee; Po-Lin Kuo; Chia-Hua Liang
Journal:  Oncotarget       Date:  2016-09-20

Review 4.  Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.

Authors:  Maria Noel Marzano Rodrigues Petruzzi; Karen Cherubini; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo
Journal:  Diagn Pathol       Date:  2017-04-05       Impact factor: 2.644

Review 5.  New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis.

Authors:  Shang-Hung Chen; Sheng-Yen Hsiao; Kwang-Yu Chang; Jang-Yang Chang
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 6.  The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression.

Authors:  Marco Tafani; Luigi Sansone; Federica Limana; Tania Arcangeli; Elena De Santis; Milena Polese; Massimo Fini; Matteo A Russo
Journal:  Oxid Med Cell Longev       Date:  2015-12-20       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.